These findings importantly show that these genes do not necessarily have a role in delayed tumor onset in Th-MYCN/Casp2−/− and/or their role in neuroblastoma onset may be counteracted by loss of Casp2. The gene discussed is MYCN; the disease is neuroblastoma.